This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges
by Sanghamitra Saha
Healthcare ETFs split as insurers stumble and pharma surges -- highlighting the necessity of smart industry picks.
Short Week Finishes with Netflix Q1 Beat
by Mark Vickery
We'd obviously welcome any positive news on the trade tariff front over the weekend, which starts tomorrow for the markets in observance of Good Friday.
UnitedHealth Lags Q1 Earnings & Revenues, Slashes Estimates
by Zacks Equity Research
UNH continues to witness significant growth in medical costs. However, its operating cost ratio improves.
Building Permits Surge in March
by Zacks Equity Research
Building Permits Surge in March
Pre-Market Drama Shifts: Dow Lower on UNH Miss
by Mark Vickery
Since April 2nd, the Dow is -7.65%, the S&P 500 -6.71%, the Nasdaq -6.19% and the small-cap Russell 2000 -8.62%.
UnitedHealth (UNH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
UnitedHealth Group (UNH) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of -0.96% and 1.40%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Should Invesco S&P 500 Revenue ETF (RWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for RWL
Zacks Investment Ideas feature highlights UnitedHealth, Newmont and Sprouts Farmers Market
by Zacks Equity Research
UnitedHealth, Newmont and Sprouts Farmers Market have been highlighted in this Investment Ideas article.
3 Stocks Flashing Bullish Momentum
by Derek Lewis
While the market continues to digest tariff headlines and other economic developments, UnitedHealth, Newmont, and Sprouts Farmers Market have all been climbing higher.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Should SPDR Dow Jones Industrial Average ETF (DIA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DIA
CVS Health vs. UnitedHealth: Which Healthcare Stock Has More Upside?
by Urmimala Biswas
CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now? Let's take a closer look.
Key Large Cap Reports to Watch This Week
by Derek Lewis
The 2025 Q1 earnings season picks up considerably this week, with large-cap companies Progressive and UnitedHealth helping to headline the reporting docket. What can investors expect?
What Makes UnitedHealth Group (UNH) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Gear Up for UnitedHealth (UNH) Q1 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of UnitedHealth (UNH) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Beat the Market the Zacks Way: Casey's, Stride, McDonald's in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
How Should You Play UnitedHealth Stock Going Into Q1 Earnings?
by Kaibalya Pravo Dey
UNH's first-quarter earnings are likely to have benefited from growing premiums and service revenues.
JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, Wells Fargo, Morgan Stanley, Netflix, UnitedHealthcare, Johnson & Johnson and CSX Corp have been highlighted in this Earnings Preview article.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
by Zacks Equity Research
Sector ETF report for XLV
UnitedHealth (UNH) Moves 5.4% Higher: Will This Strength Last?
by Zacks Equity Research
UnitedHealth (UNH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
UnitedHealth vs. Humana: Which Healthcare Stock Should You Buy Now?
by Kaibalya Pravo Dey
The CMS announced a hike in MA payments for fiscal year 2026, which will likely deliver a notable boost to UNH & HUM's bottom lines.
Company News for Apr 9, 2025
by Zacks Equity Research
Companies in The News Are: UNH, TSLA, CEG, ALB
5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout
by Nalak Das
Despite Extreme volatility, these five stocks have provided more than 4% returns past month. These are: SFM, UNH, SRAD, GME, PODD.
Markets Reverse Direction as Tariff Ante Upped on China
by Mark Vickery
An additional +50% tariffs on Chinese imports are now getting levied as of midnight tonight.